SCHEMBL1317299

SCHEMBL1317299

CC(C)(C)OC(=O)c1ccc(-c2ccccc2)cc1NC(=O)c1cc(-c2cncnc2)ccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 13/20 0.46
HDAC2 Q92769 1/20 0.43
ABL1 P00519 2/20 0.42
KDM4E B2RXH2 1/20 0.41
APOBEC3A P31941 1/20 0.41
GFER P55789 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
ACLY P53396 2/20 0.41
DHFR P00374 1/20 0.40
HNF4A P41235 1/20 0.40
MCL1 Q07820 1/20 0.40
ACMSD Q8TDX5 1/20 0.40
KCNMA1 Q12791 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRA6 Q16445 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1319007 0.92 HDAC1 (0.53) HDAC1HDAC2KDM4EAPOBEC3AGFER
SCHEMBL12117634 0.91 HDAC1 (0.53) HDAC1HDAC2HDAC3
SCHEMBL12117654 0.90 HDAC1 (0.42) HDAC1HDAC2ABL1ACLYGABRA1
SCHEMBL12117621 0.90 HDAC1 (0.54) HDAC1HDAC2KDM4EAPOBEC3AGFER
SCHEMBL1315812 0.86 HDAC1 (0.49) HDAC1HDAC2KDM4EAPOBEC3AGFER
SCHEMBL1317888 0.85 HDAC1 (0.49) HDAC1HDAC2KDM4EAPOBEC3AGFER
SCHEMBL1319925 0.85 ACLY (0.56) HDAC1HDAC2KDM4EAPOBEC3AGFER
SCHEMBL12117755 0.85 HDAC1 (0.48) HDAC1HDAC2KDM4EAPOBEC3AGFER
SCHEMBL1317363 0.84 HDAC1 (0.50) HDAC1HDAC2KDM4EAPOBEC3AGFER
SCHEMBL1316188 0.84 LRRK2 (0.52) HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102333757-B N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD 2014-11-26 CN disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 HDAC1 73/4885HDAC2 857/4885ABL1 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.